Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q3

4521.TEDINET S100Q58K
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥55.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥76.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥57.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥12.4bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥13.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥17.5bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥14.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥12.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥14.5bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥10.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥167.8bnat 2022-12-31Cons.Assets
Total assets¥165.2bnat 2022-03-31Cons.Assets
Total assets¥169.9bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥27.1bnat 2022-12-31Cons.Liabilities
Total liabilities¥26.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥140.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥138.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥139.7bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥55.9bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥61.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥243.312022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.992022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥251.432021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥269.412021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥93.22021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio83.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥11.4bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-12-31¥960m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.4bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2021-04-01 → 2021-12-31¥55.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2021-04-01 → 2021-12-31¥55.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2021-04-01 → 2021-12-31¥12.9bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2021-04-01 → 2021-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2021-04-01 → 2021-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2021-04-01 → 2021-12-31¥998m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥57.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥57.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥13.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 381
ItemContextValueUnit
Short term loans payablePrior1YearInstant3850000000JPY
Short term loans payableCurrentQuarterInstant3850000000JPY
Income taxes payablePrior1YearInstant2436000000JPY
Income taxes payableCurrentQuarterInstant1509000000JPY
Provision for bonusesPrior1YearInstant984000000JPY
Provision for bonusesCurrentQuarterInstant464000000JPY
Other clPrior1YearInstant5838000000JPY
Other clCurrentQuarterInstant5916000000JPY
Current liabilitiesPrior1YearInstant19049000000JPY
Current liabilitiesCurrentQuarterInstant19413000000JPY
Provision for share based remuneration nclPrior1YearInstant106000000JPY
Provision for share based remuneration nclCurrentQuarterInstant70000000JPY
Net defined benefit liabilityPrior1YearInstant5039000000JPY
Net defined benefit liabilityCurrentQuarterInstant4925000000JPY
Deferred tax liabilitiesPrior1YearInstant2229000000JPY
Deferred tax liabilitiesCurrentQuarterInstant2229000000JPY
Other nclPrior1YearInstant431000000JPY
Other nclCurrentQuarterInstant424000000JPY
Noncurrent liabilitiesPrior1YearInstant7806000000JPY
Noncurrent liabilitiesCurrentQuarterInstant7649000000JPY
LiabilitiesPrior1YearInstant26855000000JPY
LiabilitiesCurrentQuarterInstant27063000000JPY
Capital stockPrior1YearInstant23853000000JPY
Capital stockCurrentQuarterInstant23853000000JPY
Capital surplusPrior1YearInstant11406000000JPY
Capital surplusCurrentQuarterInstant11406000000JPY
Retained earningsPrior1YearInstant126347000000JPY
Retained earningsCurrentQuarterInstant129844000000JPY
Treasury stockPrior1YearInstant-28714000000JPY
Treasury stockCurrentQuarterInstant-30026000000JPY
Shareholders equityPrior1YearInstant132893000000JPY
Shareholders equityCurrentQuarterInstant135078000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant4551000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant4698000000JPY
Remeasurements of defined benefit plansPrior1YearInstant301000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant349000000JPY
Valuation and translation adjustmentsPrior1YearInstant4853000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant5047000000JPY
Non controlling interestsPrior1YearInstant578000000JPY
Non controlling interestsCurrentQuarterInstant578000000JPY
Net assetsPrior1YearInstant138325000000JPY
Net assetsCurrentQuarterInstant140704000000JPY
Liabilities and net assetsPrior1YearInstant165181000000JPY
Liabilities and net assetsCurrentQuarterInstant167767000000JPY
Net salesPrior1YTDDuration57708000000JPY
Net salesCurrentYTDDuration55573000000JPY
Cost of salesPrior1YTDDuration25689000000JPY
Cost of salesCurrentYTDDuration25010000000JPY
Gross profitPrior1YTDDuration32019000000JPY
Gross profitCurrentYTDDuration30562000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass